The Maze Procedure in Mitral Vale Disease Ki-Bong Kim, MD Dept. of Thoracic & Cardiovascular Surgery Seoul National University Hospital.

Slides:



Advertisements
Similar presentations
Atrial Fibrillation Cardiovascular ISCEE 26th October 2010.
Advertisements

Off pump CABG has been performed for the first time 40 years ago. Although conventional CABG is considered both safe and effective, the use of CBP.
A major teaching hospital of Harvard Medical School
Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University
Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
AVR: Choice of Prosthesis Tirone E. David University of Toronto.
1/ Incidence of AF: 5% of the population > 60 years, candidates for AF surgery in USA 2/ Etiologies: among patients applying for a life insurance:
STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
Mitral Stenosis. Etiology Most cases of mitral stenosis are due to rheumatic fever The rheumatic process causes immobility and thickening of the mitral.
© Continuing Medical Implementation …...bridging the care gap Valvular Heart Disease Aortic Stenosis.
Peking University Dayi Hu Sept 16, IHF,Beijing, 2005 Atrial Fibrillation in China.
Radiofrequency Maze Operation for Permanent Atrial Fibrillation
SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK Marc Gillinov, M.D. For the CTSN Investigators.
SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK Marc Gillinov, M.D. For the CTSN Investigators.
Atrial fibrillation wavelets propagating in different directions disorganised atrial depolarisation without effective atrial contraction f waves
CABG GUIDELINES SANJAY DRAVID, M.D.. INTRODUCTION ACC/AHA GUIDELINE UPDATE FOR CORONARY ARTERY BYPASS GRAFT SURGERY (JACC 2004; 44: AND CIRCULATION.
Clinical Title Date Jaret Tyler, MD Clinical Cardiac Electrophysiologist Assistant Professor of Medicine Ohio State’s Heart and Vascular Center Atrial.
Treating Atrial Fibrillation Richard Schilling St Bartholomew's Hospital, Queen Mary’s University of London.
SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK Marc Gillinov, M.D. For the CTSN Investigators.
How to Do A Mitral Valve Repair for Rheumatic Valve Disease
Boston Children’s Hospital, Harvard Medical School
Audit of ablation procedures for AF Barts and The London.
Heart Transplantation for Patients with a Fontan Procedure
Dubrava University Hospital Zagreb, Croatia DEPARTMENT OF CARDIAC SURGERY RF Ablation of Atrial Fibrillation in Valvular Heart Surgery Patients.
Late outcomes of the Cox-Maze IV procedure for atrial fibrillation Matthew C. Henn MD, Timothy S. Lancaster MD, Jacob R. Miller MD, Laurie A. Sinn RN,
THE RHYTHM IN LIFE THE SEASONS DO NOT PUSH ONE ANOTHER; NEITHER DO CLOUDS RACE THE WIND ACROSS THE SKY. ALL THINGS HAPPEN IN THEIR OWN GOOD TIME.
Ventricular Diastolic Filling and Function
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Dr. Mehdi Reza Emadzadeh Department of cardiology Mashhad University of Medical Science.
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
M Ruel, V Chan, M Boodhwani, B McDonald, X Ni, G Gill, K Lam, F Rubens, P Hendry, R Masters, T Mesana Ottawa, Canada How Detrimental is Re-Exploration.
Is an Antithrombotic Therapy necessary after Mitral Valve Repair ? Ph Meurin, JY Tabet, MC Iliou, B Pierre, S Corone et A Bendriss, On behalf of the Working.
Cardiac Intervention in the Elderly. Cardiac Interventions Coronary Artery Bypass Grafting (CABG) Percutaneous Transluminal Coronary Angioplasty (PTCA)
Department of Surgery, University of Pennsylvania Health System Which Operation is Best for Severe Ischemic MR: Repair or Replace? Michael Acker William.
Randomized Trial of Ea rly S urgery Versus Conventional Treatment for Infective E ndocarditis (EASE) Duk-Hyun Kang, MD, PhD on behalf of The EASE Trial.
Long-term Benefits of Surgical Pulmonary Embolectomy for Acute Pulmonary Embolus on Right Ventricular Function Brent Keeling MD 1, Bradley G. Leshnower.
Redo afib ablation John R Onufer MD FHRS
A Contemporary Analysis of Pulmonary Hypertension in Patients Undergoing Mitral Valve Surgery: Is this a Risk Factor? Thank you to the society and panel.
Clinical Review AbioCor® Implantable Replacement Heart H Julie Swain M.D. Cardiovascular Surgeon Ileana Piña M.D. Heart Failure Cardiologist DRAFT.
Does amiodarone work in prevention of postoperative AF for patients with CAD s/p CABG? 麻醉科 R1 楊美惠 麻醉科 R1 楊美惠.
The Placement of Atrial Pacing Leads in Patients after Cardiac Surgery
Exercise Management Atrial Fibrillation Chapter 9.
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
The Reoperative Aortic Root: Degenerative Failure vs. Infectious Destruction – Outcomes of The “True Redo-Root” Reconstruction Rita K. Milewski, Arminder.
Cardiac Rehabilitation after Mitral Valve Repair Ph Meurin, MC Iliou, A Bendriss, B Pierre, S Corone,P Cristofini et JY Tabet On behalf of the Working.
Experiences with Ultracinch and Ultrawand HIFU Techniques for Ablation Therapy M. Dalrymple-Hay FRCS FECTS PhD Consultant Cardiac Surgeon Declared Interests.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Pacemaker following adult cardiac surgery DR M HASANZADEH MUMS NOV 2014.
+ Mitral Valve Prolapse A Surgeon’s Perspective Charles Anderson, M.D. Saint Joseph’s Hospital of Atlanta.
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients with Heart Failure with preserved Ejection Fraction Effect of Spironolactone.
Asymptomatic mitral regurgitation When should you operate? Ben Bridgewater Cardiac surgeon and lead clinician, UHSM, Manchester Honorary Reader, Manchester.
Causes of Heart Valve Dysfunction Congenital defects (bicuspid aortic valve) Infections (rheumatic fever and bacterial endocarditis Coronary artery disease.
Objective Bleeding events are grave and sometimes life threatening complications after prosthetic valve replacement, especially in hemodialysis patients.
The Place of Closed Mitral Valvotomy Procedure in Facility Deprived Countries in the Modern PTMC/PMBV Era: 20 Years Experience at SMS Hospital, Jaipur,
Thanks ………… Echocardiographic Evaluation Of Prosthetic Cardiac Valves Dr Gaurav Kumar Chaudhary MD,DM( Cardiology) Assistant Professor Department of Cardiology.
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
© free-ppt-templates.com 2017 AHA/ACC Focused Update of Valvular Heart Disease Guideline of 2014 DR. OMAR SHAHID TR CARDIOLOGY SZH.
James S. Tweddell, MD Warren W. Bailey Endowed Chair,
Minimally Invasive Mitral Valve Repair
Jeff Macemon MBChB, PDMSM Advanced Trainee, CTS
Mitral Regurgitation: Epidemiology, Pathophysiology and When to Repair
University of Pennsylvania Philadelphia
Is There a Need to Address AF in patients Undergoing Valve Surgery?
Early Recovery of Left Ventricular Systolic Function After CoreValve Transcatheter Aortic Valve Replacement Harold L. Dauerman, MD; Michael J. Reardon,
Dr M B Connellan Stellenbosch University
Successful Cox Maze Procedure During Mitral Valve Surgery Restores Patient Survival Without Increasing Operative Risk Niv Ad, MD Chief, Cardiac Surgery.
Homograft Replacement of the aortic valve:Ten-year results
James W.W. Wong, MD, Koon-Hou Mak, MD, FACC 
Presentation transcript:

The Maze Procedure in Mitral Vale Disease Ki-Bong Kim, MD Dept. of Thoracic & Cardiovascular Surgery Seoul National University Hospital

Atrial Fibrillation Atrial Fibrillation Prevalence : % of general population 8-17 % of population > 60 yrs % in pts w/ MV disease % in pts undergoing surgery for Tx of MV disease Incidence of asso. thromboembolism : 33 % 75 % of episodes can involve the brain 60 % of those events can result in death or severe morbidity

Three Untoward Effects of AF Unpleasantness of an irregular heart beat Impaired hemodynamics because of the loss of AV synchrony Vulnerability to the thromboembolic complications

  The extended op time needed for complicated multiple atrial incisions may preclude application of the CM-III as a concomitant op w/ standard OHS.   We modified the CM-III to decrease op time, while retaining the important principles of the maze incisions. The Cox-Maze III Procedure

Conventional CM-IIIModified CM-III Modification of the Cox-Maze III Procedure Ki-Bong Kim, et al Ann Thorac Surg 2001;71:816-22

An 8½ -Year Clinical Experience with Surgery for Atrial Fibrillation Cox JL, et al Ann Surg 1996;224:267-75

Methods  Sept 1987 – March 1996  164 pts between 3 mo & 8½ yrs after op CM-I ; 32 pts CM-II ; 14 pts CM-III ; 118 pts  59 pts (33%) underwent concomitant op in addition to the Maze procedure Ann Surg 1996;224:267

Surgical Indications  Arrhythmia intolerance ; DOE, easy fatigability, lethargy, malaise, general sense of impending doom during AF  Drug intolerance ; unsuccessful tx of max amount of tolerable drug therapy  Previous TE ; significant temporary or permanent neurological deficit  Documented cerebral TE in the absence of other demonstrable etiologies  absolute Ix for surgery because anticoagulation does not protect from a second stroke Ann Surg 1996;224:267

Indications for Surgical Tx for AF Indication n / Total % Arrhythmia Intolerance 118 / Drug Intolerance 16 / Previous TE 44 /

Results  93 % ; arrhythmia free w/o any antiarrhythmic medication  7 % ; converted to SR w/ medical tx  Of the 107 pts who were documented to have normal SA node pre-op, only 1 pt required a permanent PM Ann Surg 1996;224:267

Restoration of Atrial Transport Function Following the MAZE procedure Procedure RA Function (+) LA Function (+) Maze-I 32/32 (100%) 23/32 (72%) Maze-II 11/11 (100%) 7/11 (64%) Maze -III 80/82 (98%) 77/82 (94%) Total 123/125 (98%) 107/125 (86%)

Contraindications  Significant LV dysfunction, not attributable to the arrhythmia itself  Concomitant cardiac / non-cardiac disease that constitutes an excessive surgical risk  Pts w/ severe HOCM because of the excessive risk asso. w/ the combined procedures Ann Surg 1996;224:267

Restoration of Atrial Function After the Maze Procedure for Patients with Atrial Fibrillation ; Assessment by Doppler Echocardiography Feinberg MS, et al Circulation 1994;5 (pt II):II

METHODS  46 pts  8 ± 7 mo after the Maze  Additional procedures in 13 pts Circulation 1994;5 (pt II):II-285

RESULTS Restoration of RA contraction ; 83% (38/46) LA contraction ; 61% (28/46) % atrial filling fraction of RA that of LA % atrial filling fraction of RA in pts w/ active atrial contraction was comparable to that of control (32±7 vs 33±8 %, p=NS), whereas that of LA was smaller (20±5 vs 36±7 %, p<0.05). Circulation 1994;5 (pt II):II-285

The Outcome and Indications of the Cox Maze III Procedure for Chronic Atrial Fibrillation With Mitral Valve Disease Isobe F, et al J Thorac Cardiovasc Surg 1998;116:220-7

METHODS  30/34 pts w/ AF + MV disease  4 pts were excluded  3 w/ incomplete cut & suture d/t severe calcification & adhesions  1 died of post LV rupture  21 Rheumatic 8 Degenerative 1 PVF JTCVS 1998;116:220

RESULTS  F/U > 6 mo after the op (2.1±0.9 yrs)  SR was restored in 27 pts (90%)  RA contractility (+) in 100 % (27/27)  LA contractility (+) in 67 % (18/27)  AF persisted in 3 pts (10%) JTCVS 1998;116:220

RESULTS (SR group vs AF group RESULTS (SR group vs AF group )  f-wave voltage in lead V1  0.23±0.10 vs 0.06±0.05 mV p=0.01  CTR  60±5 vs 78±10 % p=  LA systolic dimension (Doppler)  57±8 vs 95±24 mm p=  AF duration  5.1±4.6 vs 11.8±5.5 yrs p= » » Predisposing factors for the post-op persistence of AF JTCVS 1998;116:220

RESULTS  No pts resumed SR when CTR ≥ 70 % & LA systolic dimension ≥ 80 mm before the op JTCVS 1998;116:220

RESULTS  A/E ratio of trans-mitral flow was low in pts w/ the Maze procedure as compared w/ the normal valve  Regarding the restoration of LA function, f-wave voltage, CTR, & LA systolic dimension showed no significant difference between the pts w/ positive & negative a-waves, & only the duration of AF showed statistically significant difference ( p=0.011 ). JTCVS 1998;116:220

Rationale of the Cox Maze Procedure for Atrial Fibrillation During Redo Mitral Valve Operations Kobayashi J, Kosakai Y, Isobe F, et al J Thorac Cardiovasc Surg 1996;112:

METHODS  42 pts w/ redo MV + Maze procedure  37 Kosakai’s modified Maze 2 CM-II 3 CM-III  F-U after op : 25.5 ± 10.8 mo.  Control group : 54 pts w/ redo MV w/o Maze procedure JTCVS 1996;112:1216

RESULTS  SR was regained in 28/42 pts (67 %)  Doppler study LA contraction in 16/28 pts (57%) RA contraction in 21/28 pts (75 %) JTCVS 1996;112:1216

Comparison between pts w/ & w/o restored sinus rhythm Variables SR (+) SR(-) p-value No Age (yr) 57.8± ±9.3 NS Rheumatic 23(82%) 13(94%) NS Duration of AF (yr) 9.0± ± f-wave on V1 (mV) 0.18± ± CT ratio (%) 63±8 67± LAD (mm) 57±9 57±6 NS

JTCVS 1996;112:1216 Results of op in the maze & control groups Maze group Control groupp-value Maze group Control group p-value No ACC time (min) 133±28 121± CPB time (min) 211±43 197± C-tube drainage(ml) 890± ±480 NS Blood transfusion (ml) 2120± ±1760 NS # Transfusion 7(17%) 11(20%) NS Hospital Mortality 0(0%) 4(7.4%) NS Bleeding reop 6(14%) 4(7.4%) NS Mediastinitis 0(0%) 2(3.7%) NS

CONCLUSION  The Maze procedure should be considered in selected pts who have a high possibility of regaining SR during redo MV op.  The Maze procedure should be performed concomitantly w/ MVR while preserving the MV apparatus for moderately depressed LV function, inasmuch as atrial contraction is very important. JTCVS 1996;112:1216

The Cox Maze III Procedure for Atrial Fibrillation Associated With Rheumatic Mitral Valve Disease Ki-Bong Kim, et al Ann Thorac Surg 1999;68:

METHODS  75 CM-III pts for AF asso w/ rheumatic MV disease  14 cases ; Reop because of PVF ANTS 1999;68:799

INDICATIONS  Indications to perform concomitant CM-III Chronic AF >1 yr LA thrombi (+) Medical history of previous TE events in the absence of other demonstrable etiologies ANTS 1999;68:799

RESULTS  In-hospital Mortality ; 2.7% (2/75)  73 survivors were followed for 30±13 mo (12-56) ANTS 1999;68:799

Cardiac Rhythms in the Latest F-U NSR 66 / 73 (90 %) NSR 66 / 73 (90 %)  w/o drug therapy 60 (82 %)  w/ addition of one drug 6 (8 %) AF 3 / 73 (4 %) AF 3 / 73 (4 %) JR 2 / 73 (3 %) JR 2 / 73 (3 %) PM implantation 2 / 73 (3 %) PM implantation 2 / 73 (3 %) ANTS 1999;68:799

Follow-Up TTE  66 pts w/ NSR  RA contractility (+) : 66 / 66 (100 %) LA contractility (+) : 41 / 66 (62 %)* LA contractility (+) : 41 / 66 (62 %)*  Restoration of RA contractility : 69±93 days Restoration of LA contractility :126±136 days* Restoration of LA contractility :126±136 days* * * p < 0.05 ANTS 1999;68:799

Factors Predisposing to Persisting AF Factors NSR (n=66) AF (n=3) p-value (univariate) Age (>60 yrs) 13.6 % 33.3 % ns AF Duration (>60 Mo) 40.9 % % ns LAD (>55 mm) 63.1 % 66.7 % ns LVEDD (>55 mm) 36.9 % 33.3 % ns EF (<45 %) 23.1 % 33.3 % ns

Factors Affecting Recovery of LA Contractility Factors LA(+) LA(-) p-value Factors LA(+) LA(-) p-value Univariate Multivariate Univariate Multivariate Age (<60 yrs) 87.5% 92.3% NS Duration of AF (<60 mo) 75.0% 42.3% LAD (<55 mm) 41.0 % 38.5 % NS EF (>45 %) 74.4% 80.8% NS mPAP (<20 mmHg) 19.0% 14.3% NS C.I. (>2.0 L/min/m2) 72.4% 37.5% NS RA contractility (<60 d) 75.0% 37.5% < 0.01

Non-redo vs. Redo OHS Non-redo Redo p-value Non-redo Redo p-value AF duration (Mo) 52±57 132±91 <0.01 ACC time (min) 154±45 137±32 ns CPB time (min) 250±69 258±95 ns C-tube drain (ml) 985± ±261 ns Bleeding reop 3 1 ns Conversion rate (%) ns

Conclusions  CM-III for AF asso w/ RMVD demonstrated a high sinus conversion rate & recovery of atrial contractility  LA contractility is restored significantly later & a lower rate than RA contractility in RMVD  CM-III can be performed in redo op w/ comparable sinus conversion rate & acceptable op risk ANTS 1999;68:799

Restoration of Atrial Mechanical Function After Maze Operation in Patients With Structural Heart Disease Kim Y-J, Sohn D-W, et al Am Heart J 1998;136:1070-4

METHODS  32 pts w/ the Maze procedure  SR was restored in 81 % (26/32) By surgery alone in 69 % (22/32)  By the addition of one drug in 13% (4/32)  Of the remaining 6 pts,  Four (13%, 4/32) pts ; paroxysmal AF despite antiarrhythmic therapy  One ; sustained AF  One ; permanent PM insertion d/t SSS Am Heart J 1998;136:1070

RESULTS  RA function (+) ; 30 / 30 pts w/ SR or paroxysmal AF  LA function (+) ; 19 / 30 pts (63 %) Am Heart J 1998;136:1070

RESULTS  Peak A velocity & A/E ratio of mitral inflow in pts w/ restored LA function, were significantly lower than in the 16 post-op control pts (p<0.01). Am Heart J 1998;136:1070

RESULTS  In pts w/ LA mechanical function, duration of AF was significantly shorter than in pts w/o LA mechanical function (1.9±2.9 vs 7.1±3.0 yrs, p<0.01), but there were no significant differences in LA size & volume. Am Heart J 1998;136:1070

Surgical Outcome of Maze Procedure for Atrial Fibrillation in Mitral Valve Disease: Rheumatic versus Degenerative JW Lee,et al. STS meeting, 2002

Group R (n=86) : Rheumatic Group D (n=43) : Degenerative Study interval : Immediate postop 3 Mo 6 Mo

Sinus Conversion Rate (%) P >0.05 P < 0.05

Impact of the Maze Procedure on the Stroke Rate in Patients with Atrial Fibrillation Cox JL, et al J Thorac Cardiovasc Surg 1999;118:833-40

Methods  Sept March 1999  306 pts w/ the maze procedure  paroxysmal (intermittent) AF ; 61 % chronic (continuous) AF ; 39 % chronic (continuous) AF ; 39 % JTCVS 1999;188:833

Peri-op Stroke Rates for the Major Categories of Cardiac Surgical Procedures 5.90 % 5.00 % 4.53 % 4.24 % 3.30 % 3.26 % 2.96 % 2.44 % 0.65 % 1.73 % 1.73 % 1.60 % 1.60 % 1.41 % 1.41 % 1.51 % 1.51 % 1.45 % 1.45 % 0.98 % 0.98 % 1.23 % 1.23 % 0.75 % 0.75 % 0 % 0 % 4.17 % 3.40 % 3.12 % 2.73 % 1.85 % 2.28 % 1.73 % 1.69 % 0.65 % CABG + MVR CABG + AVR CABG + MV repair AVR + MVR MV repair MVRAVRCABG Maze ± other % total stroke % transient % transient stroke stroke % permanent stroke Procedures

Whether should the pts w/o LA contractile function after the maze undergo anticoagulation?  Normal RA function & normal RA-RV synchrony  Normal right-sided CO that is delivered to left side of heart through pulmonary circulation  No difference whether LA is contracting (in the presence of normal LV) because LV will immediately adapt to normal right-sided output that has just been delivered to it  Normal LA inflow volume, regular LV filling, & no LAA to serve as a nidus for thrombus formation  There is no reason to suspect that systemic TE would be any higher in these pts than those w/ demonstrable LA contraction JTCVS 1999;188:833

 When properly performed, the results w/ this combined approach have been excellent, w/ no increase in periop morbidity or op mortality & w/ documented long-term advantages over simply leaving pts in AF. James L. Cox - James L. Cox J Thorac Cardiovasc Surg 2001;122:212 EPILOGUE